Rhythmlink International is pleased to announce a significant update regarding our company’s leadership, which came into effect April 1. Following careful consideration and thoughtful planning, Rhythmlink is delighted to introduce Paul Buckman as the new Chief Executive Officer (CEO) and member of the Board of Directors at Rhythmlink.
Buckman brings over 30 years of experience in the medical device and life sciences sectors, including senior leadership roles at St. Jude Medical, Pathway Medical Technologies, and LivaNova PLC. Buckman’s impressive history of success, coupled with his strategic vision and innovative approach, positions him to lead Rhythmlink to new levels of achievement.
Shawn Regan, Co-founder of Rhythmlink, has assumed the role of Chairman of the Board, where he will continue to provide strategic guidance and mentorship to the organization. In addition, he will continue to be a significant investor in the company. Regan’s unwavering commitment and leadership have been key to Rhythmlink’s growth and success over the past 22 years. His significant contributions during his tenure as Co-founder and CEO have made a lasting impact on the culture of Rhythmlink as well as the neurodiagnostic industry.
“I’m delighted with my new role and looking forward to working with Paul as this change in leadership marks an exciting new chapter for Rhythmlink,” said Regan. “Under Paul’s guidance as CEO, we will continue to build upon our existing strengths in the ever-evolving neurodiagnostic space. The opportunities for Rhythmlink are numerous and I’m excited to see our continued growth while we extend our focus and dedication to providing the highest level of customer service and improving patient care.”
To learn more or keep up with the company’s latest news, visit Rhythmlink.com or follow Rhythmlink on LinkedIn or Facebook.
About Rhythmlink:
Rhythmlink is a designer and manufacturer of single-use brain health and neurodiagnostic solutions. Rhythmlink serves electroencephalography (“EEG”), intraoperative neuromonitoring (“IONM”), and electromyography (“EMG”) end markets through its broad disposable portfolio of FDA Cleared Conditional MR EEG electrodes, CT imaging compatible electrodes, subdermal needles, EMG electrodes, and other neurodiagnostic products. The company focuses on improving patient care through strategic innovation designed with the medical professional in mind. Focus areas include workflow efficiencies, labor cost savings, reduction in training time, and lower rates of costly hospital-acquired infections. Headquartered in Columbia, SC, the company has 300+ employees and enjoys a fully owned and operated manufacturing and assembly facility. Rhythmlink has been named to Inc. 5000’s Fastest Growing Companies list 8 times and has been named one of the Best Places to Work in South Carolina 12 years running. Rhythmlink was acquired by Graham Partners, a private investment firm, in March 2023.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240419653007/en/